Your browser doesn't support javascript.
loading
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
Nikolaou, Vasiliki; Sibaud, Vincent; Fattore, Davide; Sollena, Pietro; Ortiz-Brugués, Ariadna; Giacchero, Damien; Romano, Maria Concetta; Riganti, Julia; Lallas, Konstantinos; Peris, Ketty; Voudouri, Dimitra; Lallas, Aimilios; Fabbrocini, Gabriella; Lazaridou, Elisabeth; Carrera, Cristina; Annunziata, Maria Carmela; Rossi, Ernesto; Patri, Angela; Rigopoulos, Dimitrios; Stratigos, Alexander J; Apalla, Zoe.
Afiliación
  • Nikolaou V; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece. Electronic address: drviknik@yahoo.com.
  • Sibaud V; Institut Universitaire du cancer, Toulouse Oncopole, Toulouse, France.
  • Fattore D; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Sollena P; Department of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico "A. Gemelli" Istituto di Ricerca e Cura a Carattere Scientifico, Rome, Italy.
  • Ortiz-Brugués A; Hospital Clinic Barcelona, Barcelona, Spain.
  • Giacchero D; Centre Antoine Lacassagne, Nice, France.
  • Romano MC; San Camillo Forlanini Hospital, Rome, Italy.
  • Riganti J; Hospital Italiano of Buenos Aires, Buenos Aires, Argentina.
  • Lallas K; First Dermatology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Peris K; Department of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico "A. Gemelli" Istituto di Ricerca e Cura a Carattere Scientifico, Rome, Italy.
  • Voudouri D; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece.
  • Lallas A; First Dermatology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Lazaridou E; Second Dermatology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Carrera C; Hospital Clinic Barcelona, Barcelona, Spain.
  • Annunziata MC; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Rossi E; Division of Medical Oncology, Fondazione Policlinico "A. Gemelli" Istituto di Ricerca e Cura a Carattere Scientifico, Rome, Italy.
  • Patri A; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Rigopoulos D; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece.
  • Stratigos AJ; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece.
  • Apalla Z; Second Dermatology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
J Am Acad Dermatol ; 84(5): 1310-1320, 2021 May.
Article en En | MEDLINE | ID: mdl-33279646
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Acad Dermatol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Acad Dermatol Año: 2021 Tipo del documento: Article